- Home
- CQP vs IQV Comparison
CQP vs IQV Comparison
Compare CQP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CQP
- IQV
- Stock Information
- Founded
- CQP 2003
- IQV 1982
- Country
- CQP United States
- IQV United States
- Employees
- CQP N/A
- IQV N/A
- Industry
- CQP Oil/Gas Transmission
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CQP Utilities
- IQV Health Care
- Exchange
- CQP Nasdaq
- IQV Nasdaq
- Market Cap
- CQP 26.1B
- IQV 31.0B
- IPO Year
- CQP 2007
- IQV 2013
- Fundamental
- Price
- CQP $54.02
- IQV $187.76
- Analyst Decision
- CQP Strong Sell
- IQV Strong Buy
- Analyst Count
- CQP 5
- IQV 19
- Target Price
- CQP $54.60
- IQV $229.37
- AVG Volume (30 Days)
- CQP 85.2K
- IQV 1.2M
- Earning Date
- CQP 10-30-2025
- IQV 10-30-2025
- Dividend Yield
- CQP 6.08%
- IQV N/A
- EPS Growth
- CQP N/A
- IQV N/A
- EPS
- CQP 4.12
- IQV 6.92
- Revenue
- CQP $9,959,000,000.00
- IQV $15,700,000,000.00
- Revenue This Year
- CQP $32.89
- IQV $6.01
- Revenue Next Year
- CQP $4.69
- IQV $5.05
- P/E Ratio
- CQP $13.10
- IQV $27.11
- Revenue Growth
- CQP 10.62
- IQV 3.60
- 52 Week Low
- CQP $47.50
- IQV $134.65
- 52 Week High
- CQP $68.42
- IQV $249.54
- Technical
- Relative Strength Index (RSI)
- CQP 45.98
- IQV 53.87
- Support Level
- CQP $53.45
- IQV $177.82
- Resistance Level
- CQP $55.75
- IQV $192.13
- Average True Range (ATR)
- CQP 0.93
- IQV 4.48
- MACD
- CQP 0.01
- IQV -1.14
- Stochastic Oscillator
- CQP 36.95
- IQV 54.02
About CQP Cheniere Energy Partners LP Common Units
Cheniere Energy Partners is a liquified natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.